NewGenIvf
NIVF
1 hedge funds and large institutions have $10.8K invested in NewGenIvf in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
26% less capital inflows, than outflows
Capital inflows: $31.1K | Capital outflows: $41.7K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marex Group
London,
|
+$31.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu Financial
New York
|
-$17K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$15.9K |
| 3 |
XTX Topco
George Town,
Cayman Islands
|
-$7.21K |
| 4 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
-$1.6K |
| 5 |
Tower Research Capital (TRC)
New York
|
-$64 |
NIVF Hedge Fund Activity: Q2 2025 in Review
1 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in NewGenIvf (NIVF) for Q2 2025, worth a combined $10.8K — down 74% from $41.7K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NIVF positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Marex Group, opening a new position worth an estimated $31.1K. The largest seller was Virtu Financial, cutting an estimated $17K.
- 1 institutional investor held NewGenIvf (NIVF) as of Q2 2025, up from 0 in Q1 2025.
- Funds reported $10.8K of NewGenIvf stock for Q2 2025, down 74% quarter-over-quarter.
- 1 fund opened new NewGenIvf positions in Q2 2025 and 0 closed out, a net change of +1 holder.
- The largest NewGenIvf buyer in Q2 2025 was Marex Group, an estimated $31.1K added.
- The largest NewGenIvf seller in Q2 2025 was Virtu Financial, an estimated $17K sold.
Based on aggregated 13F filings for Q2 2025.